These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 30597042

  • 1. Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training.
    Newman AA, Grimm NC, Wilburn JR, Schoenberg HM, Trikha SRJ, Luckasen GJ, Biela LM, Melby CL, Bell C.
    J Clin Endocrinol Metab; 2019 Jun 01; 104(6):1953-1966. PubMed ID: 30597042
    [Abstract] [Full Text] [Related]

  • 2. Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans.
    Ryan SPP, Newman AA, Wilburn JR, Rhoades LD, Trikha SRJ, Godwin EC, Schoenberg HM, Battson ML, Ewell TR, Luckasen GJ, Biela LM, Melby CL, Bell C.
    Nutrients; 2020 Feb 18; 12(2):. PubMed ID: 32085394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aerobic power and insulin action improve in response to endurance exercise training in healthy 77-87 yr olds.
    Evans EM, Racette SB, Peterson LR, Villareal DT, Greiwe JS, Holloszy JO.
    J Appl Physiol (1985); 2005 Jan 18; 98(1):40-5. PubMed ID: 15591302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial.
    Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP, Boemke-Zelch F, Linz P, Nagel AM, Titze J, Uder M, Schmieder RE.
    Cardiovasc Diabetol; 2018 Jan 04; 17(1):5. PubMed ID: 29301520
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice.
    Millar PJ, Pathak V, Moffett RC, Pathak NM, Bjourson AJ, O'Kane MJ, Flatt PR, Gault VA.
    Mol Cell Endocrinol; 2016 Jan 15; 420():37-45. PubMed ID: 26607806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of Endurance Training on the Skeletal Muscle Nitric Oxide Metabolism in Insulin-Independent Type 2 Diabetic Men-A Pilot Study.
    Brinkmann C, Schulte-Körne B, Grau M, Obels S, Kemmerling R, Schiffer T, Bloch W, Brixius K.
    Metab Syndr Relat Disord; 2017 Feb 15; 15(1):52-58. PubMed ID: 27782779
    [Abstract] [Full Text] [Related]

  • 14. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors].
    Valek R, Von der Mark J.
    Med Klin Intensivmed Notfmed; 2017 Mar 15; 112(2):145-148. PubMed ID: 27221094
    [Abstract] [Full Text] [Related]

  • 15. Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
    Nambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Nakano I, Furihata T, Katayama T, Yamanashi K, Obata Y, Saito A, Yokota T, Kinugawa S.
    Eur J Pharmacol; 2020 Jan 05; 866():172810. PubMed ID: 31738936
    [Abstract] [Full Text] [Related]

  • 16. Faster heart rate and muscular oxygen uptake kinetics in type 2 diabetes patients following endurance training.
    Koschate J, Drescher U, Brinkmann C, Baum K, Schiffer T, Latsch J, Brixius K, Hoffmann U.
    Appl Physiol Nutr Metab; 2016 Nov 05; 41(11):1146-1154. PubMed ID: 27819153
    [Abstract] [Full Text] [Related]

  • 17. Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
    Ferrannini E, Baldi S, Frascerra S, Astiarraga B, Heise T, Bizzotto R, Mari A, Pieber TR, Muscelli E.
    Diabetes; 2016 May 05; 65(5):1190-5. PubMed ID: 26861783
    [Abstract] [Full Text] [Related]

  • 18. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
    Reed JW.
    Vasc Health Risk Manag; 2016 May 05; 12():393-405. PubMed ID: 27822054
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.